P2X Purinergic Receptors Are Multisensory Detectors for Micro-Environmental Stimuli That Control Migration of Tumoral Endothelium.
calcium signaling
cell migration
purinergic receptors
tumor-derived endothelial cells
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
31 May 2022
31 May 2022
Historique:
received:
18
05
2022
accepted:
30
05
2022
entrez:
10
6
2022
pubmed:
11
6
2022
medline:
11
6
2022
Statut:
epublish
Résumé
The tumoral microenvironment often displays peculiar features, including accumulation of extracellular ATP, hypoxia, low pH-acidosis, as well as an imbalance in zinc (Zn
Identifiants
pubmed: 35681724
pii: cancers14112743
doi: 10.3390/cancers14112743
pmc: PMC9179260
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Italian Ministry for University and Research (MUR)
ID : 20174TB8KW
Références
Purinergic Signal. 2013 Dec;9(4):491-540
pubmed: 23797685
PLoS One. 2008 Jul 09;3(7):e2599
pubmed: 18612415
Front Pharmacol. 2017 Nov 22;8:860
pubmed: 29213241
Am J Physiol Heart Circ Physiol. 2000 Jul;279(1):H285-92
pubmed: 10899068
Cancer Biol Ther. 2011 Dec 1;12(11):939-48
pubmed: 22057267
Oncotarget. 2016 Mar 22;7(12):13464-78
pubmed: 26859576
Cancer Metastasis Rev. 2019 Jun;38(1-2):113-129
pubmed: 30607627
Glia. 2008 Apr;56(5):528-38
pubmed: 18240314
Handb Exp Pharmacol. 2009;(194):283-332
pubmed: 19655111
Redox Biol. 2017 Aug;12:499-504
pubmed: 28340463
Cells. 2021 Jan 19;10(1):
pubmed: 33477845
Oncogene. 2017 Jan 19;36(3):293-303
pubmed: 27321181
Rev Physiol Biochem Pharmacol. 2022;182:111-137
pubmed: 32809072
N Engl J Med. 2005 Jan 27;352(4):373-9
pubmed: 15673803
J Mol Biol. 2015 Jan 16;427(1):54-66
pubmed: 24937752
Neuropharmacology. 2009 Jan;56(1):208-15
pubmed: 18657557
Front Physiol. 2013 Dec 05;4:354
pubmed: 24367336
Pharmacol Rev. 2013 Dec 11;66(1):102-92
pubmed: 24335194
Oncotarget. 2016 Sep 6;7(36):58649-58658
pubmed: 27462915
BJU Int. 2008 Feb;101(3):352-9
pubmed: 18005209
Front Mol Neurosci. 2019 Aug 07;12:183
pubmed: 31440138
Rev Neurosci. 2011;22(3):335-54
pubmed: 21639805
Porto Biomed J. 2019 Jul 08;4(4):e45
pubmed: 31930179
Hepatology. 2008 Feb;47(2):698-705
pubmed: 18027885
Recent Pat Anticancer Drug Discov. 2019;14(1):32-38
pubmed: 30652649
Recent Pat Anticancer Drug Discov. 2018;13(4):422-427
pubmed: 29807523
BMC Cancer. 2014 Dec 12;14:939
pubmed: 25494980
Biomed J. 2017 Oct;40(5):245-256
pubmed: 29179879
J Exp Clin Cancer Res. 2020 Sep 30;39(1):204
pubmed: 32993787
Cancer Cell. 2014 Nov 10;26(5):605-22
pubmed: 25517747
Annu Rev Physiol. 2019 Feb 10;81:43-62
pubmed: 30354932
Pflugers Arch. 2006 Aug;452(5):513-37
pubmed: 16649055
Biochem J. 2003 Aug 15;374(Pt 1):51-61
pubmed: 12747800
PLoS One. 2015 Jul 17;10(7):e0133346
pubmed: 26186602
Biomaterials. 2017 Feb;116:118-129
pubmed: 27914984
Nat Commun. 2018 Apr 10;9(1):1354
pubmed: 29636447
Int J Mol Sci. 2019 Dec 07;20(24):
pubmed: 31817884
Int J Mol Sci. 2020 Apr 23;21(8):
pubmed: 32340289
Br J Pharmacol. 2021 Feb;178(3):489-514
pubmed: 33125712
J Cell Biochem. 2007 Jul 1;101(4):937-49
pubmed: 17171643
J Neurochem. 2007 Apr;101(1):17-26
pubmed: 17394459
J Gen Physiol. 2011 Oct;138(4):437-52
pubmed: 21911484
Purinergic Signal. 2005 Dec;1(4):299-310
pubmed: 18404515
Free Radic Biol Med. 2020 Nov 20;160:775-783
pubmed: 32927017
Cancers (Basel). 2019 Jun 01;11(6):
pubmed: 31159426
Mol Oncol. 2016 Jan;10(1):166-78
pubmed: 26433470
Sci Rep. 2016 Sep 02;6:32602
pubmed: 27586846